Long-term Risk of Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib. Winthrop KL, Vermeire S, Long MD, Panes J, et al. Inflamm Bowel Dis 2022 Jun 1. pii: 6596831. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Winthrop KL, Vermeire S, Long MD, Panes J, et al. Long-term Risk of Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib. Inflamm Bowel Dis 2022 Jun 1. pii: 6596831. doi: 10.1093.
PMID: 35648151